Table 6.

Distribution of the study population by diabetes complications variables in relation to the presence of MetS or its absence and at different PA levels.

Diabetes complications		Activity level category						P	Metabolic syndrome				Total		P
		IA (n=476)		SA (n=307)		VA (n=417)			Presence		Absence
		No.	%	No.	%	No.	%		No.	%	No.	%	No.	%
Eye problems	Yes	348	73.1	161	52.4	185	44.4		518	74.6	176	25.4	694	100
	No	128	26.9	146	47.6	232	55.6	.001	230	45.5	276	54.5	506	100	.001
Kidney	Yes	89	18.7	23	7.5	18	4.3		122	93.8	8	6.2	130	100
problems	No	387	81.3	284	92.5	399	95.7	.001	626	58.5	444	41.5	1070	100	.001
Protein in	Yes	361	75.8	159	51.8	118	28.3		512	80.3	126	19.7	638	100
urine	No	115	24.2	148	48.2	299	71.7	.001	236	42.0	326	58.0	562	100	.001
Heart	Yes	59	12.4	14	4.6	14	3.4		84	96.6	3	3.4	87	100
problems	No	417	87.6	293	95.4	403	96.6	.001	664	59.7	449	40.3	1113	100	.001
Extremities	Yes	187	39.3	54	17.6	23	5.5		235	89.0	29	11.0	264	100
problems	No	289	60.7	253	82.4	394	94.5	.001	513	54.8	423	45.2	936	100	.001
Neurological	Yes	467	98.1	286	93.2	353	84.7		721	65.2	385	34.8	1106	100
problems	No	9	1.9	21	6.8	64	15.3	.001	27	28.7	67	71.3	94	100	.001

Activity level category measured in metabolic equivalents per week (MET/wk): IA= insufficiently active (≤600 MET/wk); SA= sufficiently active (601 to 1500 MET/wk); and VA= very active (≥1500 MET/wk).

Descriptive statistics, Crosstabs, the chi-square test was used to examine difference in the prevalence of different categorical variable. P value less than 0.05 was considered as statistically significant.